Severe COVID-19 patients with high levels of NT-proBNP had a significantly higher mortality risk in comparison to patients with low levels [537,538], advocating for NT-proBNP as a biomarker to predict the risk of in-hospital death in COVID-19 patients. Here, NPPB is linked to COVID-19.